Donald Trump was elected the 47th president of the United States after winning the required 270 seats in the November 5 election. Despite the victory, it remains unclear what Trump's second term as president will mean for the healthcare industry. During the campaign, Republicans said little about health policy, but they talked about getting Robert F. Kennedy Jr. “hot” in the medical field and helping RFK Jr. “do what he wants” in women's health care. He made several declarations, including: Despite President Trump's reluctance to formally declare his former third-party rival a Cabinet member, RFK Jr. He said he was…
Author: admin
Revenue: USD 8.84 million (up 127% from Q3 2023). Net income: USD 1.22 million (up from a loss of USD 1.45 million in Q3 2023). Margin: 14% (up from net loss in Q3 2023). The transition to profitability was driven by revenue growth. EPS: USD 0.074 (up from loss of USD 0.089 in Q3 2023). NasdaqCM:SRTS Earnings and Revenue Growth November 17, 2024 All numbers shown in the chart above are for the trailing 12 month (TTM) period. Sales exceeded analysts' expectations by 50%. Earnings per share (EPS) also exceeded analyst expectations. Looking ahead, revenues are expected to increase by…
We recently published a list of the 8 most promising healthcare stocks by hedge funds. In this article, we'll take a look at how AbbVie Inc. (NYSE:ABBV) stands compared to the other most promising healthcare stocks, according to hedge funds. The healthcare sector relies on advances in medical technology, particularly devices used to prevent, diagnose, and treat diseases. Unlike pharmaceuticals, medical devices work through physical or mechanical means rather than chemical processes. Major products include pacemakers, imaging devices, dialysis machines, and implants. The healthcare sector is growing in the United States. According to recent estimates, the country's health spending will…
Revenue: RM12.3 million (up 7.0% from Q3 2023). Net profit: RM1.5 million (stable with Q3 2023). Profit margin: 12% (same as Q3 2023). EPS: RM0.002 (consistent with Q3 2023). KLSE:METRO Earnings and Revenue History as of November 24, 2024 All numbers shown in the chart above are for the trailing 12 month (TTM) period. Looking ahead, revenues are expected to grow by an average of 12% over the next three years, compared to a growth forecast of 6.2% for the Malaysian healthcare industry. Malaysian healthcare industry performance. The company's stock price has fallen 12% from a week ago. What about…
We recently published a list of the 8 most promising healthcare stocks by hedge funds. In this article, we'll take a look at how Johnson & Johnson (NYSE:JNJ) stands compared to the other most promising healthcare stocks, according to hedge funds. The healthcare sector relies on advances in medical technology, particularly devices used to prevent, diagnose, and treat diseases. Unlike pharmaceuticals, medical devices work through physical or mechanical means rather than chemical processes. Major products include pacemakers, imaging devices, dialysis machines, and implants. The healthcare sector is growing in the United States. According to recent estimates, the country's health spending…
We recently published a list of the 8 most promising healthcare stocks by hedge funds. In this article, we'll take a look at how Eli Lilly & Company (NYSE:LLY) stands compared to the other most promising healthcare stocks, according to hedge funds. The healthcare sector relies on advances in medical technology, particularly devices used to prevent, diagnose, and treat diseases. Unlike pharmaceuticals, medical devices work through physical or mechanical means rather than chemical processes. Major products include pacemakers, imaging devices, dialysis machines, and implants. The healthcare sector is growing in the United States. According to recent estimates, the country's health…
We recently compiled a list of 10 oversold healthcare stocks to invest in. In this article, we'll take a look at how Moderna, Inc. (NASDAQ:MRNA) stands compared to other oversold healthcare stocks. Investing in healthcare stocks during economic downturns is generally considered defensive. This is because people typically do not reduce their use of prescription drugs and other important health services even during economically difficult times. National health spending is projected to reach an estimated $4.8 trillion in 2023 and grow at an annual rate of 5.6% from 2027 to 2032, according to the Centers for Medicare and Medicaid Services…
We recently compiled a list of the 10 worst-performing healthcare stocks of 2024. In this article, we'll take a look at how Moderna, Inc. (NASDAQ:MRNA) stands compared to other healthcare stocks. The healthcare industry continues to be an important and resilient sector driven by technological advances, increasing global demand, and an aging population. ReportLinker predicts that the healthcare services industry will grow from $7.5 trillion in 2022 to $7.975 trillion in 2023. It is expected to grow at a compound annual growth rate (CAGR) of 6.3%, or $9.8 trillion, through 2027. The global healthcare market is divided into several segments…
We recently compiled a list of the 10 worst-performing healthcare stocks of 2024. In this article, we'll take a look at how Biogen, Inc. (NASDAQ:BIIB) stands compared to other healthcare stocks. The healthcare industry continues to be an important and resilient sector driven by technological advances, increasing global demand, and an aging population. ReportLinker predicts that the healthcare services industry will grow from $7.5 trillion in 2022 to $7.975 trillion in 2023. It is expected to grow at a compound annual growth rate (CAGR) of 6.3%, or $9.8 trillion, through 2027. The global healthcare market is divided into several segments…
IHH Healthcare Berhad (KLSE:IHH) announced its third quarter results last week. We wanted to see how the business is performing and what industry forecasters think about the company following this report. Results appear to be mixed. Although sales were slightly below analysts' expectations of RM5.6 billion, statutory profit was in line with expectations at RM0.34 per share. Earnings results are an important time for investors as they can track a company's performance, see what analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We've collected the latest statutory forecasts to see…